42 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 22 Not applicable, 13 Phase 3, 7 Phase 2, 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 22 | Completed 21, Active not recruiting 1 |
| Phase 3 | 13 | Completed 12, Recruiting 1 |
| Phase 2 | 7 | Completed 6, Withdrawn 1 |
| Phase 4 | 5 | Completed 4, Unknown 1 |
Follow Tin Fluorides: new trials by email Literature Review of Tin Fluorides trials Research Report on Tin Fluorides
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice Stannous fluoride and Potassium nitrate Dentifrice, Stannous fluoride Dentifrice, Potassium nitrate Dentifrice - Dentin Hypersensitivity | Phase 3 | Completed | HALEON | 688 | 2025-09-16 | 2026-08-25 |
| Heart Failure Polypill at a Safety Net Hospital Heart failure polypill, Control Rx - Heart Failure With Reduced Ejection Fraction, HIV Infections | Phase 2 | Completed | University of California, San Francisco | 35 | 2024-02-27 | 2025-12-31 |
| A Real-World Evidence Study Evaluating Oral Health Related Quality Of Life With Use Of A Stannous Fluoride Anti-Sensitivity Toothpaste For Dentin Hypersensitivity Management Stannous fluoride - Dentin Sensitivity | Not applicable | Completed | HALEON | 536 | 2023-09-21 | 2025-04-24 |
| Evaluation of the Anticaries Efficacy of Dentifrice Formulations Using an In-situ Model Oral-B 1450 ppm Fluoride (1.16% sodium monofluorophosphate) Dentifrice, Colgate 1450 ppm Fluoride (1.16% sodium monofluorophosphate)Dentifrice, Toms of Maine 0 ppm Fluoride Dentifrice - Caries | Not applicable | Completed | Procter and Gamble | 12 | 2023-07-31 | 2024-02-29 |
| Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC Experimental drug, Control Rx - Metastatic Microsatellite-stable Colorectal Cancer | Phase 3 | Recruiting | Sun Yat-sen University | 176 | 2023-03-01 | 2023-03-14 |
| The Impact of Intravenous Vitamin C Combined With Nerve Blocks on Postoperative Pain and Recovery After Total Knee Arthroplasty Ascorbic acid 100mg/kg, Maximus 10g, Control Rx - Ascorbic Acid, Postoperative Pain | Not applicable | Completed | Chimei Medical Center | 73 | 2022-11-02 | 2025-11-19 |
| Discontinuation of Antiviral Therapy as a Strategy to Cure Hepatitis B Stopping - Hepatitis B, Chronic | Not applicable | Active not recruiting | Göteborg University | 33 | 2022-11-01 | 2025-04-17 |
| Comparision of the Clinical Efficacy of Different Desensitizing Toothpastes Sodium Monofluorophosphate, Stannous Fluoride, Nano-Hydroxyapatite - Dentine Hypersensitivity | Not applicable | Completed | Altinbas University | 48 | 2022-05-01 | 2024-01-09 |
| Stannous Fluoride and Gingivitis Stannous fluoride - Gingivitis | Not applicable | Completed | Procter and Gamble | 40 | 2022-04-11 | 2022-06-16 |
| A Three Month Bleeding-Model Clinical Study 0.454% stannous fluoride, 0.76% sodium monofluorophosphate, 0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM - Gingivitis | Not applicable | Completed | Procter and Gamble | 90 | 2021-11-15 | 2023-06-23 |
| Polypill Strategy for Heart Failure With Reduced Ejection Fraction Polypill, Control Rx - Heart Failure | Phase 2 | Completed | University of Texas Southwestern Medical Center | 212 | 2021-11-15 | 2025-11-21 |
| Effectiveness in Dental Plaque Reduction of Mouthwashes Containing Fatty Acids Compounds (F.A.G.) or Stannous Fluoride Fatty Acids Compounds (F.A.G.) Mouthwash, Stannous Fluoride (SF) Mouthwash - Gingivitis, Gingival Diseases | Not applicable | Completed | University of L'Aquila | 34 | 2021-09-01 | 2023-09-26 |
| Effectiveness of Toothpaste Containing the Active Ingredient of Galla Chinensis Extract on Treating Dentin Hypersensitivity galla chinensis, Stannous fluoride - Tooth Sensitivity | Not applicable | Completed | Minia University | 90 | 2021-05-20 | 2023-10-18 |
| Erector Spinae Block Versus Thoracic Paravertebral Block for Acute Thoracic Herpes Zoster Control Rx, Erector Spinae Block, Thoracic Paravertebral Block - Acute Thoracic Herpes Zoster, Erector Spinae Plane Block | Phase 4 | Unknown | Tanta University | 90 | 2020-12-05 | 2020-12-08 |
| A Bleeding-Model Clinical Study 0.454% stannous fluoride, 0.76% sodium monofluorophosphate, 0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM - Gingivitis | Not applicable | Completed | Procter and Gamble | 90 | 2020-10-19 | 2023-06-23 |
| Salivary SARS-CoV-2 Load of Covid-19 Patients After Oral Antimicrobial Solutions and Dentifrices Colgate Periogard® mouthwash, Colgate Peroxyl® mouthwash, Colgate Total® Mouthwash - Corona Virus Infection | Not applicable | Completed | Hospital Israelita Albert Einstein | 202 | 2020-07-14 | 2022-02-25 |
| Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris AdvVEGF-D, Control Rx - Refractory Angina Pectoris, Gene Transfer | Phase 2 | Completed | Kuopio University Hospital | 63 | 2019-10-19 | 2025-01-13 |
| Study to Characterize the Efficacy of a Dual Active Dentifrice for the Relief of Dentin Hypersensitivity Potassium Nitrate, Stannous Fluoride - Dentin Hypersensitivity, Dentin Sensitivity | Phase 2 | Completed | GlaxoSmithKline | 123 | 2019-05-13 | 2020-09-11 |
| Clinical Investigation of a Toothpaste Containing Stannous Fluoride as Compared to Colgate Fluoride Toothpaste Colgate Total SF, Colgate Cavity Protection toothpaste - Gingivitis | Phase 4 | Completed | Colgate Palmolive | 88 | 2019-03-06 | 2022-09-27 |
| Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18) Empagliflozin, Dulaglutide, Control Rx - Non-Alcoholic Fatty Liver Disease, Liver Steatosis | Completed | National and Kapodistrian University of Athens | 78 | 2018-06-01 | 2023-07-14 |
Showing 20 of 46. Sign in to see all of them.
Dentin Sensitivity (16) · Gingivitis (11) · Heart Failure (2) · Agnosia (1) · Angina Pectoris (1) · Colorectal Neoplasms (1) · Coronary Artery Disease (1) · Coronavirus Infections (1) · Dental Calculus (1) · Dental Caries (1) · Dental Plaque (1) · Fatty Liver (1) · Gingival Diseases (1) · HIV Infections (1) · Hepatitis B, Chronic (1)
GlaxoSmithKline (16) · Procter and Gamble (7) · Colgate Palmolive (5) · HALEON (2) · Altinbas University (1) · Chimei Medical Center (1) · Federal University of São Paulo (1) · Göteborg University (1) · Helsinki University Central Hospital (1) · Hospital Israelita Albert Einstein (1) · Kuopio University Hospital (1) · Minia University (1) · National and Kapodistrian University of Athens (1) · Pearl Network (1) · Sun Yat-sen University (1)
United States (18) · Canada (4) · China (4) · Egypt (2) · Finland (2) · Thailand (2) · United Kingdom (2) · Australia (1) · Brazil (1) · Denmark (1) · Germany (1) · Greece (1) · Ireland (1) · Italy (1) · Sweden (1)
Ashley C Grill, MPH, RDH (1) · Aurimery G Chermont (1) · Bennet Amaechi, PhD, DDS (1) · Colette DeJong, MD (1) · Daniel Fine, DDS (1) · Debora H Douek, PhD (1) · Dutmanee Seriwatanachai (1) · Frederick A Curro, DMD, PhD (1) · Jeff Milleman (1) · Jeffery L Milleman (1) · Jen-Yin Chen (1)
PMID 31164116, PMID 27093773, PMID 39118360, PMID 19948613, PMID 26437498, PMID 31352795, PMID 31640741, PMID 32216778, PMID 32391584, PMID 34059275, PMID 35570015, PMID 37127210, PMID 38130922, PMID 39215289, PMID 40118491, PMID 41212166, PMID 42393373